taurolidine has been researched along with Cancer of Ovary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlert, C; Kanis, S; Klee, D; Melchert, F; Volz, J; Volz-Köster, S | 1 |
| Calabresi, P; Darnowski, JW; Goulette, FA | 1 |
2 other study(ies) available for taurolidine and Cancer of Ovary
| Article | Year |
|---|---|
Modulation of tumor-induced lethality after pneumoperitoneum in a mouse model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Disease Models, Animal; Female; Heparin; Mice; Mitoxantrone; Neoplasm Transplantation; Ovarian Neoplasms; Peritoneal Neoplasms; Pilot Projects; Pneumoperitoneum, Artificial; Survival Analysis; Taurine; Thiadiazines; Tumor Cells, Cultured | 2000 |
Taurolidine: cytotoxic and mechanistic evaluation of a novel antineoplastic agent.
Topics: 3T3 Cells; Animals; Antineoplastic Agents; Apoptosis; Cell Division; DNA Fragmentation; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Nude; Ovarian Neoplasms; Taurine; Thiadiazines; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2001 |